Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

COMPASS Pathways

Biotech & Life Sciences · London, United Kingdom · Founded 2016 · IPO 2020 Unicorn

Psilocybin-based therapies for treatment-resistant mental health conditions

Valuation
$1.11B
Market cap · May/2026
Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

23 investors on COMPASS Pathways's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 3 investors entered at this stage
XYence
Thor Bjorgolfsson
Mike Novogratz
Series B+ 20 investors entered at this stage
Aisling Capital
Able Partners
RA Capital Management
WPSS.bio
ATAI Life Sciences
Presight Capital
Skyviews Life Science
Perceptive Advisors
Paradigm BioCapital
Surveyor Capital
Logos Capital
Founders Fund
Laurion Capital Management
TCGX
Armistice Capital
McQuade Center for Strategic Research and Development
Vivo Capital
Soleus Capital
Camden Partners
PFM Health Sciences

Global footprint

Where COMPASS Pathways has talent and traffic

AI talent share
1.2% of workforce is AI talent
(3 of 248 staff)
Core AI20.81%
Other AI10.4%
Non-AI workforce24598.79%
Workforce by country
9 countries with
team presence
🇺🇸 United States47%
🇬🇧 United Kingdom46.7%
🇪🇸 Spain1.8%
🇦🇺 Australia1.2%
🇨🇦 Canada1.2%
Top 5 of 9 shown
Web traffic by country
34K monthly visits
across markets
🇺🇸 United States46.8%
🇬🇧 United Kingdom14.7%
🇨🇦 Canada8.8%
🇵🇭 Philippines7.4%
🇪🇸 Spain5.3%
Top 5 markets shown

Patent intelligence

$106M patent portfolio · 48 active families

Estimated portfolio value
$106M
9.5% of market cap · comparable to top peer Resilience ($108M)
48 active patent families
Where COMPASS Pathways innovates PsilocybinPharmacologyMedicinal chemistryDiseaseAttention deficits

Where COMPASS Pathways concentrates vs peers

Each axis is a top-10 topic across COMPASS Pathways and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about COMPASS Pathways

An AI-synthesized read of the highest-engagement posts about COMPASS Pathways on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See COMPASS Pathways on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles